BG Medicine (BGMD) Affirms Receipt of CE Mark for Galectin-3 Assay (ABT)

April 10, 2013 8:19 AM EDT Send to a Friend
BG Medicine, Inc. (Nasdaq: BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login